As shown in Figure 3B, the area under the curve of HOXB9 for predicting the prognosis of HNSCC patients was 0.918, and that for 1-, 3-, and 5-year survival probabilities were 0.557, 0.613, and 0.582 respectively. This evidence concerns the gene HOXB9 and head and neck squamous cell carcinoma.